CPRX News and Press, Catalyst Pharmaceuticals Inc. From 10/01/21

The following slide deck was published by Catalyst Pharmaceuticals, Inc. in conjunction with this event. For further details see: Catalyst Pharmaceuticals (CPRX) Presents At 2021 Cantor Virtual Global Healthcare Conference

CORAL GABLES, Fla., Sept. 30, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare ...

CORAL GABLES, Fla., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare ...

The pharmaceutical industry’s increased focus on developing better treatments for many of today's most complex diseases should help it to grow for the foreseeable future. However, because highly priced pharma stocks are susceptible to anticipated market volatility in the near term, we ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Robinhood (NASDAQ: HOOD ) stock is catching flak on Wednesday as the company faces scrutiny for its “free share of stock” promotions. Source: mundissima / Shutterstock.com For those that don ...

Robinhood Markets (NASDAQ:HOOD) is getting some pressure for its marketing tactic of giving customers a free share of stock for opening an account or referring friends. The company is facing scrutiny from regulators and may have to shoulder the cost of distributing proxy materials to the shar...

CORAL GABLES, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing and commercializing novel high-quality medicines for patients living with rare di...

Shares of Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX) traded today at $6.23, eclipsing its 52-week high. So far today approximately 301,000 shares have been exchanged, as compared to an average 30-day volume of 754,000 shares. Catalyst Pharmaceuticals Inc is a biopharmaceutical company. ...

Image source: The Motley Fool. Catalyst Pharmaceuticals, inc (NASDAQ: CPRX) Q2 2021 Earnings Call Aug 10, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Catalyst Pharmaceuticals, inc (CPRX) Q2 2021 Earnings Call Tr...

Catalyst Pharmaceuticals, Inc. (CPRX) Q2 2021 Earnings Conference Call August 10, 2021 08:30 ET Company Participants Ali Grande - Chief Financial Officer Patrick McEnany - Chairman and Chief Executive Officer Steven Miller - Chief Operating Officer and Chief Scientific Officer Jeffrey Del Car...